The alliance aims to reduce Atlanta-area construction workers' exposure to respirable crystalline silica.
The June 3, all-day forum in Rockville, Md., is part of a years-long process in which the agency’s staff has encouraged the development of and tested sensor technologies that would shut down a gas heater when the CO concentration exceeds 400 ppm.
The agency has finished its nationwide equipment installation for the NextGen Aircraft Tracking System.
The FDA has approved Tanzeum subcutaneous injection for those living with type 2 diabetes. FDA is requiring post-marketing studies for Tanzeum, including a clinical trial to evaluate dosing, efficacy, and safety in pediatric patients.
JAMA has published a paper by a team led by Drs. Mary Rogers and Jeffrey Rohde of the University of Michigan. They examined the association between two types of transfusion strategies and health care-associated infections.
The Division of Workers' Compensation is accepting public comments until April 21.
Sen. Tom Harkin, D-Iowa, and 10 Democratic colleagues in Congress released a report highlighting how e-cigarette companies are marketing and flavoring their products to appeal to young people.
The agency reported that 2013 overall injury rates improved to a historic low.
Residents of Giglio Island received another briefing April 14 about the salvage project's next phase.
The Dallas and Chicago OSHA offices have formed an alliance with the Philippine consulate general in Chicago.
They agreed to cooperate on a project meant to improve safety and environmental standards in the industry. It will be executed by the Marine Environment Division of IMO, in partnership with the Ministry of Industries of Bangladesh, during the next 18 months.
The public meeting comes just more than a year after the explosion destroyed a fertilizer storage plant, killing 14 people and injuring more than 250.
The Office for Nuclear Regulation has been established as a Public Corporation under the Energy Act 2013.
It coincides with recent medical breakthroughs that have made more effective, safer oral hepatitis medicines available.
The FDA approves an application from Medtronic for revised labeling of certain devices.